Darya Chudova - 01 Jun 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol
GH
Transactions as of
01 Jun 2023
Net transactions value
-$26,226
Form type
4
Filing time
05 Sep 2023, 16:59:26 UTC
Previous filing
15 May 2023
Next filing
08 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +316 +2.5% $0.000000 12,740 01 Jun 2023 Direct
transaction GH COMMON STOCK Tax liability $3,453 -110 -0.86% $31.39 12,630 01 Jun 2023 Direct F1
transaction GH COMMON STOCK Options Exercise $0 +1,440 +11% $0.000000 14,070 01 Aug 2023 Direct
transaction GH COMMON STOCK Tax liability $18,922 -498 -3.5% $38.00 13,572 01 Aug 2023 Direct F1
transaction GH COMMON STOCK Options Exercise $0 +316 +2.3% $0.000000 13,888 01 Sep 2023 Direct
transaction GH COMMON STOCK Tax liability $3,851 -110 -0.79% $35.01 13,778 01 Sep 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -316 -10% $0.000000 2,841 01 Jun 2023 COMMON STOCK 316 $0.000000 Direct F2, F3
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -1,440 -100% $0.000000* 0 01 Aug 2023 COMMON STOCK 1,440 $0.000000 Direct F3, F4
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -316 -11% $0.000000 2,525 01 Sep 2023 COMMON STOCK 316 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025.
F3 Not applicable for Restricted Stock Units.
F4 The restricted stock unit award was granted on August 1, 2019, of which 1,440 shares were outstanding on May 3, 2023, when elected as an executive officer. These shares will vest on August 1, 2023.